<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The complication of <z:hpo ids='HP_0003072'>hypercalcemia</z:hpo> is reported to occur only in 2.5-4.8% of patients with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) </plain></SENT>
<SENT sid="1" pm="."><plain>We herein report a 53-year-old female patient with early B-cell ALL, complicated with extreme <z:hpo ids='HP_0003072'>hypercalcemia</z:hpo> (15.2 mg/dL) </plain></SENT>
<SENT sid="2" pm="."><plain>Bone X-ray revealed osteolytic changes in many locations </plain></SENT>
<SENT sid="3" pm="."><plain>Serum 1,25(OH)2vitaminD3 and parathyroid hormone (PTH) levels were suppressed below <z:mpath ids='MPATH_458'>normal</z:mpath> ranges on admission </plain></SENT>
<SENT sid="4" pm="."><plain>The circulating parathyroid hormone-related protein (PTHrP) value was within a <z:mpath ids='MPATH_458'>normal</z:mpath> range (&lt; 1.1 pmol/L) </plain></SENT>
<SENT sid="5" pm="."><plain>Serum concentrations of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-alpha, interleukin (IL)-6, and soluble IL-2 receptor were increased to 72 pg/ml, 25.3 pg/ml, and 1469 U/ml, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Following the induction chemotherapy, the serum calcium level was promptly normalized accompanied with decreases in serum TNF-alpha, IL-6 and soluble IL-2 receptor values to 34 pg/ml, 6.35 pg/ml, and 737 U/ml, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Serum PTHrP values remained within detectable levels </plain></SENT>
<SENT sid="8" pm="."><plain>To our knowledge, this is the first case of B-cell ALL in a patient who developed <z:hpo ids='HP_0003072'>hypercalcemia</z:hpo> with elevated concentrations of TNF-alpha, IL-6, and soluble IL-2 receptor, but not related to PTHrP </plain></SENT>
<SENT sid="9" pm="."><plain>High circulating proinflammatory cytokines may have contributed to development of ALL-induced <z:hpo ids='HP_0002797'>osteolysis</z:hpo> and <z:hpo ids='HP_0003072'>hypercalcemia</z:hpo> in the present case </plain></SENT>
</text></document>